Results 161 to 170 of about 1,829 (248)

Comparing the outcomes of the technology‐enhanced learning of sectional anatomy with and without preceding demonstrations: A study about the worked‐example effect in anatomy education

open access: yesAnatomical Sciences Education, EarlyView.
Abstract The examination of anatomical cross‐sections can facilitate the understanding of spatial and clinical anatomy. Visualization technologies, with dynamic and interactive displays, can be used to learn sectional anatomy in a mostly self‐directed manner.
Guilherme Reis Borges Coelho Fonseca   +2 more
wiley   +1 more source

[Mechanical properties of dental alloys for clasps].

open access: yesKokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan, 1977
openaire   +1 more source

Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults

open access: yesAutism Research, EarlyView.
ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a ...
Hsiang‐Yuan Lin   +3 more
wiley   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

A phase 1 evaluation of inhaled oxytocin: Physiologically‐based pharmacokinetic model informed dosing of a novel heat‐stable oxytocin delivery system

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim To develop and validate a physiologically‐based pharmacokinetic (PBPK) model enabling inhaled oxytocin dose selection for clinical evaluation. Subsequently, to conduct a phase 1 study investigating the pharmacokinetics and safety of selected doses of an optimized inhaled oxytocin product in healthy, non‐pregnant female participants.
Pete Lambert   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy